These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26294231)

  • 21. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, July-September 2023.
    Am J Health Syst Pharm; 2024 Jan; 81(2):3-4. PubMed ID: 37993264
    [No Abstract]   [Full Text] [Related]  

  • 22. Summaries of safety labeling changes approved by FDA-boxed warnings highlights, October-December 2023.
    Am J Health Syst Pharm; 2024 Apr; 81(9):e198-e205. PubMed ID: 38490964
    [No Abstract]   [Full Text] [Related]  

  • 23. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, July-September 2022.
    Am J Health Syst Pharm; 2022 Dec; 79(24):e157-e160. PubMed ID: 36377403
    [No Abstract]   [Full Text] [Related]  

  • 24. Summaries of safety labeling changes approved by FDA-Boxed warnings highlights, July-September 2022.
    Traynor K
    Am J Health Syst Pharm; 2022 Dec; 79(24):2206-2207. PubMed ID: 36342044
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs.
    Garg V; Raisch DW; McKoy JM; Trifilio SM; Holbrook J; Edwards BJ; Belknap SM; Samaras AT; Nardone B; West DP
    Expert Opin Drug Saf; 2013 May; 12(3):299-307. PubMed ID: 23480866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights.
    Klafehn CW
    Hosp Pharm; 2016 Sep; 51(8):688-691. PubMed ID: 27698510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sources of Evidence Triggering and Supporting Safety-Related Labeling Changes: A 10-Year Longitudinal Assessment of 22 New Molecular Entities Approved in 2008 by the US Food and Drug Administration.
    Croteau D; Pinnow E; Wu E; Muñoz M; Bulatao I; Dal Pan G
    Drug Saf; 2022 Feb; 45(2):169-180. PubMed ID: 35113347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coverage of FDA medication boxed warnings in commonly used drug information resources.
    Cheng CM; Guglielmo BJ; Maselli J; Auerbach AD
    Arch Intern Med; 2010 May; 170(9):831-3. PubMed ID: 20458094
    [No Abstract]   [Full Text] [Related]  

  • 29. US Food and Drug Administration Black Box Warnings.
    Smith RG
    J Am Podiatr Med Assoc; 2020 Jan; 110(1):Article10. PubMed ID: 32073327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR
    Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012.
    Cheng CM; Shin J; Guglielmo BJ
    JAMA Intern Med; 2014 Oct; 174(10):1704-5. PubMed ID: 25127107
    [No Abstract]   [Full Text] [Related]  

  • 32. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights October - December 2016.
    Rose BJ
    Hosp Pharm; 2017 Feb; 52(2):153-154. PubMed ID: 28321144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights July-September 2016.
    Rubio T
    Hosp Pharm; 2016 Dec; 51(11):941-943. PubMed ID: 28057955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of FDA safety warnings may vary.
    Kuehn BM
    JAMA; 2012 Mar; 307(9):894-5. PubMed ID: 22396504
    [No Abstract]   [Full Text] [Related]  

  • 35. The FDA Revises Boxed Warning For Fluoroquinolones-Again.
    Aschenbrenner DS
    Am J Nurs; 2016 Sep; 116(9):22-3. PubMed ID: 27560334
    [No Abstract]   [Full Text] [Related]  

  • 36. Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings Highlights.
    Rose B
    Hosp Pharm; 2016 Jun; 51(6):491-2. PubMed ID: 27354752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New and incremental FDA black box warnings from 2008 to 2015.
    Solotke MT; Dhruva SS; Downing NS; Shah ND; Ross JS
    Expert Opin Drug Saf; 2018 Feb; 17(2):117-123. PubMed ID: 29215916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility.
    Matlock A; Allan N; Wills B; Kang C; Leikin JB
    Clin Toxicol (Phila); 2011 Jul; 49(6):443-7. PubMed ID: 21591886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Value of the Black Box Warning in Dermatology.
    Winterfield L; Vleugels RA; Park KK
    J Drugs Dermatol; 2015 Jul; 14(7):660-6. PubMed ID: 26151780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing Antipsychotic Medications to Patients With Dementia: Boxed Warnings and Mitigation of Legal Liability.
    Rose RV; Kass JS
    Continuum (Minneap Minn); 2019 Feb; 25(1):254-259. PubMed ID: 30707196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.